[go: up one dir, main page]

 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (7,770)

Search Parameters:
Keywords = magnetic resonance imaging

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
19 pages, 2305 KiB  
Communication
Automated MRI Video Analysis for Pediatric Neuro-Oncology: An Experimental Approach
by Artur Fabijan, Agnieszka Zawadzka-Fabijan, Robert Fabijan, Krzysztof Zakrzewski, Emilia Nowosławska, Róża Kosińska and Bartosz Polis
Appl. Sci. 2024, 14(18), 8323; https://doi.org/10.3390/app14188323 (registering DOI) - 15 Sep 2024
Abstract
Over the past year, there has been a significant rise in interest in the application of open-source artificial intelligence models (OSAIM) in the field of medicine. An increasing number of studies focus on evaluating the capabilities of these models in image analysis, including [...] Read more.
Over the past year, there has been a significant rise in interest in the application of open-source artificial intelligence models (OSAIM) in the field of medicine. An increasing number of studies focus on evaluating the capabilities of these models in image analysis, including magnetic resonance imaging (MRI). This study aimed to investigate whether two of the most popular open-source AI models, namely ChatGPT 4o and Gemini Pro, can analyze MRI video sequences with single-phase contrast in sagittal and frontal projections, depicting a posterior fossa tumor corresponding to a medulloblastoma in a child. The study utilized video files from single-phase contrast-enhanced head MRI in two planes (frontal and sagittal) of a child diagnosed with a posterior fossa tumor, type medulloblastoma, confirmed by histopathological examination. Each model was separately provided with the video file, first in the sagittal plane, analyzing three different sets of commands from the most general to the most specific. The same procedure was applied to the video file in the frontal plane. The Gemini Pro model did not conduct a detailed analysis of the pathological change but correctly identified the content of the video file, indicating it was a brain MRI, and suggested that a specialist in the field should perform the evaluation. Conversely, ChatGPT 4o conducted image analysis but failed to recognize that the content was MRI. The attempts to detect the lesion were random and varied depending on the plane. These models could not accurately identify the video content or indicate the area of the neoplastic change, even after applying detailed queries. The results suggest that despite their widespread use in various fields, these models require further improvements and specialized training to effectively support medical diagnostics. Full article
16 pages, 1100 KiB  
Article
Food Avoidance and Aversive Goal Value Computation in Anorexia Nervosa
by Siri Weider, Megan E. Shott, Tyler Nguyen, Skylar Swindle, Tamara Pryor, Lot C. Sternheim and Guido K. W. Frank
Nutrients 2024, 16(18), 3115; https://doi.org/10.3390/nu16183115 (registering DOI) - 15 Sep 2024
Abstract
Anorexia nervosa (AN) is associated with food restriction and significantly low body weight, but the neurobiology of food avoidance in AN is unknown. Animal research suggests that food avoidance can be triggered by conditioned fear that engages the anterior cingulate and nucleus accumbens. [...] Read more.
Anorexia nervosa (AN) is associated with food restriction and significantly low body weight, but the neurobiology of food avoidance in AN is unknown. Animal research suggests that food avoidance can be triggered by conditioned fear that engages the anterior cingulate and nucleus accumbens. We hypothesized that the neural activation during food avoidance in AN could be modeled based on aversive goal value processing. Nineteen females with AN and thirty healthy controls matched for age underwent functional magnetic resonance brain imaging while conducting a food avoidance task. During active control free-bid and computer-generated forced-bid trials, participants bid money to avoid eating food items. Brain activation was parametrically modulated with the trial-by-trial placed bids. During free-bid trials, the AN group engaged the caudate nucleus, nucleus accumbens, ventral anterior cingulate, and inferior and medial orbitofrontal cortex more than the control group. High- versus low-bid trials in the AN group were associated with higher caudate nucleus response. Emotion dysregulation and intolerance of uncertainty scores were inversely associated with nucleus accumbens free-bid trial brain response in AN. This study supports the idea that food avoidance behavior in AN involves aversive goal value computation in the nucleus accumbens, caudate nucleus, anterior cingulate, and orbitofrontal cortex. Full article
(This article belongs to the Section Nutrition and Metabolism)
Show Figures

Figure 1

Figure 1
<p>Correlation slope for the calorie content of the thirty-five food items shown and mean monetary bids placed across groups.</p>
Full article ">Figure 2
<p>Brain response to low and high bid across the study groups in the caudate nucleus.</p>
Full article ">Figure 3
<p>Higher left (L) nucleus accumbens free-bid goal value computation to avoid high caloric foods was associated with lower BMI and drive for thinness; nucleus accumbens aversive goal value computation was also associated with lower scores on the Intolerance of Uncertainty Scale (IUS), and Eating Disorder Inventory Emotion Dysregulation Subscale (EDI-ED).</p>
Full article ">
16 pages, 3332 KiB  
Review
Complex Diagnostic Challenges in Glioblastoma: The Role of 18F-FDOPA PET Imaging
by David Sipos, Zsanett Debreczeni-Máté, Zsombor Ritter, Omar Freihat, Mihály Simon and Árpád Kovács
Pharmaceuticals 2024, 17(9), 1215; https://doi.org/10.3390/ph17091215 (registering DOI) - 15 Sep 2024
Viewed by 70
Abstract
Glioblastoma multiforme (GBM) remains one of the most aggressive and lethal forms of brain cancer, characterized by rapid proliferation and diffuse infiltration into the surrounding brain tissues. Despite advancements in therapeutic approaches, the prognosis for GBM patients is poor, with median survival times [...] Read more.
Glioblastoma multiforme (GBM) remains one of the most aggressive and lethal forms of brain cancer, characterized by rapid proliferation and diffuse infiltration into the surrounding brain tissues. Despite advancements in therapeutic approaches, the prognosis for GBM patients is poor, with median survival times rarely exceeding 15 months post-diagnosis. An accurate diagnosis, treatment planning, and monitoring are crucial for improving patient outcomes. Core imaging modalities such as Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) are indispensable in the initial diagnosis and ongoing management of GBM. Histopathology remains the gold standard for definitive diagnoses, guiding treatment by providing molecular and genetic insights into the tumor. Advanced imaging modalities, particularly positron emission tomography (PET), play a pivotal role in the management of GBM. Among these, 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-FDOPA) PET has emerged as a powerful tool due to its superior specificity and sensitivity in detecting GBM and monitoring treatment responses. This introduction provides a comprehensive overview of the multifaceted role of 18F-FDOPA PET in GBM, covering its diagnostic accuracy, potential as a biomarker, integration into clinical workflows, impact on patient outcomes, technological and methodological advancements, comparative effectiveness with other PET tracers, and its cost-effectiveness in clinical practice. Through these perspectives, we aim to underscore the significant contributions of 18F-FDOPA PET to the evolving landscape of GBM management and its potential to enhance both clinical and economic outcomes for patients afflicted with this formidable disease. Full article
(This article belongs to the Section Radiopharmaceutical Sciences)
Show Figures

Figure 1

Figure 1
<p>The chemical structure of <sup>18</sup>F-FDOPA.</p>
Full article ">Figure 2
<p>Left frontal post craniotomy status. Inhomogeneous, mainly centrally, moderate enhancement of contrast material is observed on T1-weighted post-contrast MRI images. The lesion in the left hemisphere is surrounded by edema (<b>C</b>,<b>D</b>). Irregularly shaped intense, focal <sup>18</sup>F-FDOPA accumulation can be detected on the left side of the brain frontally, above the level of lateral ventricles (<b>A</b>,<b>B</b>). Pink line—GTV, green line—BTV 1.7 (<b>A</b>,<b>C</b>), green line—BTV 2.0 (<b>B</b>,<b>D</b>), red line—PTV, and yellow line—recurrence [<a href="#B42-pharmaceuticals-17-01215" class="html-bibr">42</a>].</p>
Full article ">
11 pages, 512 KiB  
Article
Cine-MRI and T1TSE Sequence for Mediastinal Mass
by Matthias Grott, Nabil Khan, Martin E. Eichhorn, Claus Peter Heussel, Hauke Winter and Monika Eichinger
Cancers 2024, 16(18), 3162; https://doi.org/10.3390/cancers16183162 (registering DOI) - 15 Sep 2024
Viewed by 83
Abstract
Background/Objectives: Contrast-enhanced computed tomography (CT) is the standard radiologic examination for evaluating the extent of mediastinal tumors. If tumor infiltration into the large central thoracic vessels, the pericardium, or the myocardium is suspected, cine magnetic resonance imaging (cine-MRI) can provide additional valuable information. [...] Read more.
Background/Objectives: Contrast-enhanced computed tomography (CT) is the standard radiologic examination for evaluating the extent of mediastinal tumors. If tumor infiltration into the large central thoracic vessels, the pericardium, or the myocardium is suspected, cine magnetic resonance imaging (cine-MRI) can provide additional valuable information. Methods: We conducted a retrospective study of patients with mediastinal tumors who were staged with CT, cine-MRI, and a T1-weighted turbo spin echo (T1TSE) prior to surgical resection. Imaging was re-evaluated regarding tumor infiltration into the pericardium, myocardium, superior vena cava, aorta, pulmonary arteries, and atria and compared with intraoperative findings and postoperative histopathological reports (gold standard). Unclear CT findings were further investigated. Results: Forty-seven patients (29 female and 18 male patients; median age: 58 years) met the inclusion criteria. Cine-MRI was able to predict infiltration of the aorta in 86%, pulmonary arteries in 85%, and atria in 80% of unclear CT cases. Aortic tumor infiltration in unclear CT cases was significantly more often correctly diagnosed with cine-MRI than with T1TSE sequence. Conclusions: Additional cine-MRI is of crucial benefit in unclear CT cases. We recommend performing cine-MRI if infiltration into the large central vessels and atria is suspected. T1TSE sequence is of very limited additional value. Full article
Show Figures

Figure 1

Figure 1
<p>Patient flowchart: flowchart showing patient selection. cine-MRI = cine magnetic resonance imaging, T1TSE = magnetic resonance imaging (MRI)/T1-weighted spin echo sequences, CT = computed tomography.</p>
Full article ">
11 pages, 642 KiB  
Article
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else?
by Alessandro Perrella, Alfredo Caturano, Ilario de Sio, Pasquale Bellopede, Adelaide Maddaloni, Luigi Maria Vitale, Barbara Rinaldi, Andrea Mormone, Antonio Izzi, Costanza Sbreglia, Francesca Futura Bernardi, Ugo Trama, Massimiliano Berretta, Raffaele Galiero, Erica Vetrano, Ferdinando Carlo Sasso, Gianluigi Franci, Raffaele Marfella and Luca Rinaldi
J. Clin. Med. 2024, 13(18), 5474; https://doi.org/10.3390/jcm13185474 (registering DOI) - 14 Sep 2024
Viewed by 338
Abstract
Background: Despite achieving a sustained virological response (SVR) with direct-acting antivirals (DAAs), an unexpected increase in the occurrence rate of hepatocellular carcinoma (HCC) has been observed among HCV-treated patients. This study aims to assess the long-term follow-up of HCV patients treated with [...] Read more.
Background: Despite achieving a sustained virological response (SVR) with direct-acting antivirals (DAAs), an unexpected increase in the occurrence rate of hepatocellular carcinoma (HCC) has been observed among HCV-treated patients. This study aims to assess the long-term follow-up of HCV patients treated with DAAs who achieved an SVR to investigate the potential for late-onset HCC. Methods: In this prospective multicenter study, we enrolled consecutive HCV patients treated with DAAs following Italian ministerial guidelines between 2015 and 2018. Exclusion criteria included active HCC on imaging, prior HCC treatment, HBV or HIV co-infection, or liver transplant recipients. Monthly follow-ups occurred during treatment, with subsequent assessments every 3 months for at least 48 months. Abdominal ultrasound (US) was performed within two weeks before starting antiviral therapy, supplemented by contrast-enhanced ultrasonography (CEUS), dynamic computed tomography (CT), or magnetic resonance imaging (MRI) to evaluate incidental liver lesions. Results: Of the 306 patients completing the 48-months follow-up post-treatment (median age 67 years, 55% male), all achieved an SVR. A sofosbuvir-based regimen was administered to 72.5% of patients, while 20% received ribavirin. During follow-up, late-onset HCC developed in 20 patients (cumulative incidence rate of 6.55%). The pattern of HCC occurrence varied (median diameter 24 mm). Multivariate and univariate analyses identified liver stiffness, diabetes, body mass index, and platelet levels before antiviral therapy as associated factors for late HCC occurrence. Conclusions: Our findings suggest that late HCC occurrence may persist despite achieving SVR. Therefore, comprehensive long-term follow-up, including clinical, laboratory, and expert ultrasonography evaluations, is crucial for all HCV patients treated with DAAs. Full article
Show Figures

Figure 1

Figure 1
<p>ROC curve describing the discriminant power of the liver stiffness value (kPa) based on the risk of developing late HCC in cirrhotic patients [<span class="html-italic">n</span> = 306, AUROC score = 0.646, 95% C.I.: 0.519–0.774]. The <span class="html-italic">p</span> value for the significance of liver stiffness based on the risk of HCC was 0.029 (Kruskal–Wallis test).</p>
Full article ">
22 pages, 1279 KiB  
Review
Tailoring the Diagnostic Pathway for Medical and Surgical Treatment of Uterine Fibroids: A Narrative Review
by Gabriele Centini, Alberto Cannoni, Alessandro Ginetti, Irene Colombi, Matteo Giorgi, Giorgia Schettini, Francesco Giuseppe Martire, Lucia Lazzeri and Errico Zupi
Diagnostics 2024, 14(18), 2046; https://doi.org/10.3390/diagnostics14182046 (registering DOI) - 14 Sep 2024
Viewed by 222
Abstract
Uterine leiomyomas are the most common benign uterine tumors in women and are often asymptomatic, with clinical manifestation occurring in 20–25% of cases. The diagnostic pathway begins with clinical suspicion and includes an ultrasound examination, diagnostic hysteroscopy, and, when deemed necessary, magnetic resonance [...] Read more.
Uterine leiomyomas are the most common benign uterine tumors in women and are often asymptomatic, with clinical manifestation occurring in 20–25% of cases. The diagnostic pathway begins with clinical suspicion and includes an ultrasound examination, diagnostic hysteroscopy, and, when deemed necessary, magnetic resonance imaging. The decision-making process should consider the impairment of quality of life due to symptoms, reproductive desire, suspicion of malignancy, and, of course, the woman’s preferences. Despite the absence of a definitive cure, the management of fibroid-related symptoms can benefit from various medical therapies, ranging from symptomatic treatments to the latest hormonal drugs aimed at reducing the clinical impact of fibroids on women’s well-being. When medical therapy is not a definitive solution for a patient, it can be used as a bridge to prepare the patient for surgery. Surgical approaches continue to play a crucial role in the treatment of fibroids, as the gynecologist has the opportunity to choose from various surgical options and tailor the intervention to the patient’s needs. This review aims to summarize the clinical pathway necessary for the diagnostic assessment of a patient with uterine fibromatosis, presenting all available treatment options to address the needs of different types of women. Full article
(This article belongs to the Special Issue Exploring Gynecological Pathology and Imaging)
Show Figures

Figure 1

Figure 1
<p>Uterine leiomyoma with atypical vascular features.</p>
Full article ">Figure 2
<p>(<b>a</b>) Three-dimensional ultrasound coronal view of a uterine fibroid; (<b>b</b>) sonohysterography: sagittal view of a G0 (FIGO classification) leiomyoma.</p>
Full article ">Figure 3
<p>A pragmatic scheme to follow in the evaluation of a patient with uterine leiomyomas.</p>
Full article ">
13 pages, 3015 KiB  
Article
Evaluating the Clinical Utility of Left Ventricular Strains in Severe AS: A Pilot Study with Feature-Tracking Cardiac Magnetic Resonance
by Carmen Cionca, Alexandru Zlibut, Renata Agoston, Lucia Agoston-Coldea, Rares Ilie Orzan and Teodora Mocan
Biomedicines 2024, 12(9), 2104; https://doi.org/10.3390/biomedicines12092104 (registering DOI) - 14 Sep 2024
Viewed by 212
Abstract
Background: Aortic valve stenosis (AS) is the most common degenerative valvular heart disease, significantly impacting the outcome. Current guidelines recommend valve replacement only for symptomatic patients, but advanced cardiovascular imaging, particularly cardiac magnetic resonance (CMR), may refine these recommendations. Feature-tracking CMR (FT-CMR) effectively [...] Read more.
Background: Aortic valve stenosis (AS) is the most common degenerative valvular heart disease, significantly impacting the outcome. Current guidelines recommend valve replacement only for symptomatic patients, but advanced cardiovascular imaging, particularly cardiac magnetic resonance (CMR), may refine these recommendations. Feature-tracking CMR (FT-CMR) effectively assesses left ventricular (LV) strain and shows promise in predicting major adverse cardiovascular events (MACEs), though data on AS are limited. This study explored the role of CMR-derived LV strain in predicting MACEs occurrence in patients with severe AS. Method: We prospectively assessed 84 patients with severe AS and 84 matched controls. Global longitudinal (GLS), circumferential (GCS), and radial strain (GRS) were evaluated using FT-CMR. A composite endpoint—cardiac death, ventricular tachyarrhythmias, and heart failure hospitalization—was analyzed over a median follow-up of 31 months. Results: GLS was considerably reduced in AS patients (−15.8% vs. −19.7%, p < 0.001) and significantly predicted MACEs (HR = 1.24, p = 0.002) after adjusting for LVEF, 6 min walk distance, native T1, and late gadolinium enhancement. This underscores GLS’s unique and robust predictive capability for MACEs in severe AS patients. Kaplan–Meier curves and ROC analysis both showed that GLS had the highest predictive performance for MACEs, with an AUC of 0.857. Conclusions: GLS provided independent incremental predictive value for outcome. Full article
(This article belongs to the Section Molecular and Translational Medicine)
Show Figures

Figure 1

Figure 1
<p>Flow-chart of the study design.</p>
Full article ">Figure 2
<p>Example of post-processing feature-tracking technique using standard bSSF-CMR Images. The epicardial und endocardial contours are correspondingly drawn and LV strain metrics are graphically reported using the AHA 17-Segment model: GLS (<b>A</b>,<b>B</b>), GRS (<b>C</b>,<b>D</b>), and GCS (<b>E</b>,<b>F</b>). Usually, GLS and GCS show as negative percentage (<b>B</b>,<b>D</b>), whereas GRS show as positive one (<b>F</b>). Abbreviations: AHA, American Heart Association; GLS, global longitudinal strain; GCS, global circumferential strain; GRS, global radial strain; bSSF-CMR, balanced steady-state free precession cardiac magnetic resonance.</p>
Full article ">Figure 3
<p>ROC analysis demonstrating the ability of GLS, T1 native, ECV, and LGE. Abbreviations: GLS, global longitudinal strain; LGE, late gadolinium enhancement; ECV, extracellular volume.</p>
Full article ">Figure 4
<p>Kaplan–Meier curves for time-to-event analysis of GLS (<b>A</b>,<b>B</b>), GCS (<b>C</b>), and GRS (<b>D</b>). Abbreviations: GLS, global longitudinal strain; GCS, global circumferential strain; GRS, global radial strain.</p>
Full article ">Figure 5
<p>Incremental predictive value of GLS added to LVEF, LGE, and ECV. The <span class="html-italic">y</span>-axis represents the Chi-square values of the stepwise Cox proportional hazards models. Abbreviations: GLS, global longitudinal strain; LVEF, left ventricular ejection fraction; LGE, late gadolinium enhancement; ECV, extracellular volume.</p>
Full article ">
19 pages, 3135 KiB  
Article
Magnetic Resonance Imaging-Based Monitoring of the Accumulation of Polyethylene Terephthalate Nanoplastics
by Narmin Bashirova, Erik Butenschön, David Poppitz, Henrik Gaß, Marcus Halik, Doreen Dentel, Christoph Tegenkamp, Joerg Matysik and A. Alia
Molecules 2024, 29(18), 4380; https://doi.org/10.3390/molecules29184380 (registering DOI) - 14 Sep 2024
Viewed by 208
Abstract
Polyethylene terephthalate (PET) is one of the most produced plastic materials in the world. The emergence of microplastics and nanoplastics (MPs/NPs) as a significant environmental contaminant has become a matter of increasing concern. While the toxicological effects of PET NPs have been widely [...] Read more.
Polyethylene terephthalate (PET) is one of the most produced plastic materials in the world. The emergence of microplastics and nanoplastics (MPs/NPs) as a significant environmental contaminant has become a matter of increasing concern. While the toxicological effects of PET NPs have been widely researched, there is a lack of methodologies for studying their accumulation. The present study introduces a novel method to monitor the distribution of PET NPs in germinating wheat (Triticum aestivum L.) seeds. This involves the functionalization of superparamagnetic iron oxide nanoparticles (SPIONs) with PET NPs (PET–fSPIONs) coupled with magnetic resonance microimaging (µMRI) to provide insight into their distribution within the seed. The present study has demonstrated that PET–fSPIONs accumulate in specific regions of germinating wheat seeds, including the shoot apical meristem, the radicle, the coleoptile, the plumule, and the scutellum. Furthermore, the accumulation of PET–fSPIONs has been shown to exert a discernible effect on spin–spin relaxation (T2), as observed via MRI and quantitative T2 relaxation time analysis. The accumulation of PET NPs in embryo regions was also confirmed by SEM. Diffusion-weighted magnetic resonance imaging (DW-MRI) and non-invasive chemical shift imaging analyses demonstrated that PET NPs resulted in restricted diffusion within the highlighted areas, as well as an impact on lipid content. Our study reveals that using µMRI with fSPIONs provides a non-invasive method to monitor the biodistribution of PET nanoparticles in wheat seeds. Additionally, it offers valuable insights into the microstructural interactions of PET. Full article
14 pages, 3550 KiB  
Article
Pharmacological Inhibition of Endogenous Hydrogen Sulfide Production Slows Bladder Cancer Progression in an Intravesical Murine Model
by Sydney Relouw, George J. Dugbartey, Patrick McLeod, Natasha N. Knier, Francisco Martinez Santiesteban, Paula J. Foster, Heather-Anne Cadieux-Pitre, Nicole M. Hague, Jenna Caine, Kaitlin Belletti, Sally Major, Caroline O’Neil, Manal Y. Gabril, Madeleine Moussa, Melissa J. Huynh, Mansour S. M. Haeryfar and Alp Sener
Pharmaceuticals 2024, 17(9), 1212; https://doi.org/10.3390/ph17091212 (registering DOI) - 14 Sep 2024
Viewed by 239
Abstract
Present bladder cancer therapies have relatively limited therapeutic impact and account for one of the highest lifetime treatment costs per patient. Therefore, there is an urgent need to explore novel and optimized treatment strategies. The present study investigated the effects of inhibiting endogenous [...] Read more.
Present bladder cancer therapies have relatively limited therapeutic impact and account for one of the highest lifetime treatment costs per patient. Therefore, there is an urgent need to explore novel and optimized treatment strategies. The present study investigated the effects of inhibiting endogenous hydrogen sulfide (H2S) production on bladder cell viability and in vivo tumor progression. We targeted the H2S-producing enzyme, cystathionine γ-lyase, in 5637 cells using propargylglycine (H2S inhibitor) and performed cytofluorimetric analysis to evaluate cell viability. We then tested the efficacy of propargylglycine alone or in combination with gemcitabine (conventional chemotherapy) in an intravesical murine model of bladder cancer. Magnetic resonance imaging and immunohistochemical staining for cell proliferation, apoptosis, immune-cell infiltration, and neovascularization were performed to evaluate tumor response. Compared to control conditions or cohorts, propargylglycine administration significantly attenuated bladder cancer cell viability in vitro (p < 0.0001) and tumor growth (p < 0.002) and invasion in vivo. Furthermore, propargylglycine enhanced the anti-cancer effects of gemcitabine, resulting in tumor regression (p < 0.0001). Moreover, propargylglycine induced cleaved PARP-1-activated apoptosis (p < 0.05), as well as intratumoral CD8+ T cell (p < 0.05) and F4/80+ macrophage (p < 0.002) infiltration. Propargylglycine also reduced intratumoral neovascularization (p < 0.0001) and cell proliferation (p < 0.0002). Importantly, the pro-apoptotic and anti-neovascularization effects of gemcitabine were enhanced by propargylglycine co-administration. Our findings suggest that inhibition of endogenous H2S production can be protective against bladder cancer by enhancing the chemotherapeutic action of gemcitabine and may be a novel pharmacological target and approach for improved bladder cancer diagnosis and treatments in the future. Full article
(This article belongs to the Section Pharmacology)
Show Figures

Figure 1

Figure 1
<p>Relative gene expression of cystathionine <math display="inline"><semantics> <mrow> <mi>γ</mi> </mrow> </semantics></math>-lyase (CSE), cystathionine <math display="inline"><semantics> <mrow> <mi>β</mi> </mrow> </semantics></math>-synthase (CBS), and 3-mercaptopyruvate sulftransferase (3-MST) under hypoxic conditions. Quantitative PCR (qPCR) analysis of 5637 cells for CSE, CBS, and 3-MST gene expression levels after 8 and 36 h of hypoxia. Genes were normalized against <math display="inline"><semantics> <mrow> <mi>β</mi> </mrow> </semantics></math>-actin, and fold changes of gene expression were compared to cells exposed to 0 h of hypoxia and calculated using the ∆∆Ct method. Data (<span class="html-italic">n</span> = 5) are expressed as mean ± standard error of the mean (SEM). Means were compared using two-way ANOVA followed by Tukey’s post hoc test. * <span class="html-italic">p</span> &lt; 0.05, **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 2
<p>Cell viability and apoptosis following single and combination treatments with propargylglycine (PAG), sodium hydrosulfide (NaHS), and gemcitabine (GEM). (<b>A</b>) Cell viability and (<b>B</b>) apoptotic levels of 5637 cells following 8 h of hypoxia, single or combination treatments of 20 mM PAG, 100 <math display="inline"><semantics> <mrow> <mi mathvariant="sans-serif">μ</mi> </mrow> </semantics></math>M NaHS, and 100 <math display="inline"><semantics> <mrow> <mi mathvariant="sans-serif">μ</mi> </mrow> </semantics></math>M GEM, and an additional 24 h of hypoxia. Flow cytometry was used to quantify cell viability as the portion of cells negative for the apoptosis and necrosis markers, FITC-Annexin-V, and propidium iodide. Cell viability is represented as fold change from control cells that had undergone hypoxia without treatment. Apoptosis was quantified as the portion of cells positive for FITC-Annexin-V and negative for propidium iodide and represented as fold change from control cells that had undergone hypoxia without treatment. Data (<span class="html-italic">n</span> = 5) are expressed as mean ± SEM. Means were compared using one-way ANOVA followed by Tukey’s post hoc test. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.002, *** <span class="html-italic">p</span> &lt; 0.0002, **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 3
<p>Tumor response as evaluated by magnetic resonance imaging (MRI) and cancer presence and degree of invasion following intravesical therapy. (<b>A</b>) MRI was used to assess the change in bladder wall volume, representative of tumor progression, before and after intravesical therapy of saline, PAG, NaHS, GEM, PAG + NaHS, or PAG + GEM. Changes in bladder wall volume of the N-butyl-N-(4-hydroxybutyl) nitrosamine<sup>+</sup> (BBN<sup>+</sup>) groups were normalized to the change in bladder wall volume of the BBN<sup>−</sup> group. (<b>B</b>) Representative images of hematoxylin- and eosin-stained bladder tumor tissue; 40× magnification. Scale bar represents 100 µm. (<b>C</b>) Percentage of mice within each group that had normal tissue, dysplasia, cancer with no invasion, lamina propria (LP) invasion, or muscularis propria (MP) invasion. (<b>D</b>) Percentage of mice with no invasion, LP invasion, or MP invasion among the mice that had bladder tumors. Data are expressed as mean ± SEM. Means were compared using one-way ANOVA followed by Tukey’s post hoc test. ** <span class="html-italic">p</span> &lt; 0.002, *** <span class="html-italic">p</span> &lt; 0.0002, **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 4
<p>Immunohistochemical (IHC) staining of bladder tumors for cell proliferation, apoptosis, immune-cell infiltration, and neovascularization following intravesical therapy. (<b>A</b>) Representative images of bladder tumor samples stained for caspase-9, cleaved PARP-1, Ki67, VEGF, F4/80, CD163, CD8, and CD4 after intravesical therapy of saline, PAG, NaHS, GEM, PAG + NaHS or PAG + GEM; 40× magnification. Scale bar represents 100 µm. Arrows point to positively stained areas (<b>B</b>–<b>I</b>) Corresponding digital analyses show percent area of sections positive for caspase-9, cleaved PARP-1, Ki67, VEGF, F4/80, CD163, CD8, and CD4. Data are expressed as mean ± SEM. Means were compared using one-way ANOVA followed by Tukey’s post-hoc test. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.002, *** <span class="html-italic">p</span> &lt; 0.0002, **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 4 Cont.
<p>Immunohistochemical (IHC) staining of bladder tumors for cell proliferation, apoptosis, immune-cell infiltration, and neovascularization following intravesical therapy. (<b>A</b>) Representative images of bladder tumor samples stained for caspase-9, cleaved PARP-1, Ki67, VEGF, F4/80, CD163, CD8, and CD4 after intravesical therapy of saline, PAG, NaHS, GEM, PAG + NaHS or PAG + GEM; 40× magnification. Scale bar represents 100 µm. Arrows point to positively stained areas (<b>B</b>–<b>I</b>) Corresponding digital analyses show percent area of sections positive for caspase-9, cleaved PARP-1, Ki67, VEGF, F4/80, CD163, CD8, and CD4. Data are expressed as mean ± SEM. Means were compared using one-way ANOVA followed by Tukey’s post-hoc test. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.002, *** <span class="html-italic">p</span> &lt; 0.0002, **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">
20 pages, 6971 KiB  
Review
The Role of Cardiovascular Imaging in the Diagnosis of Athlete’s Heart: Navigating the Shades of Grey
by Nima Baba Ali, Sogol Attaripour Esfahani, Isabel G. Scalia, Juan M. Farina, Milagros Pereyra, Timothy Barry, Steven J. Lester, Said Alsidawi, David E. Steidley, Chadi Ayoub, Stefano Palermi and Reza Arsanjani
J. Imaging 2024, 10(9), 230; https://doi.org/10.3390/jimaging10090230 (registering DOI) - 14 Sep 2024
Viewed by 244
Abstract
Athlete’s heart (AH) represents the heart’s remarkable ability to adapt structurally and functionally to prolonged and intensive athletic training. Characterized by increased left ventricular (LV) wall thickness, enlarged cardiac chambers, and augmented cardiac mass, AH typically maintains or enhances systolic and diastolic functions. [...] Read more.
Athlete’s heart (AH) represents the heart’s remarkable ability to adapt structurally and functionally to prolonged and intensive athletic training. Characterized by increased left ventricular (LV) wall thickness, enlarged cardiac chambers, and augmented cardiac mass, AH typically maintains or enhances systolic and diastolic functions. Despite the positive health implications, these adaptations can obscure the difference between benign physiological changes and early manifestations of cardiac pathologies such as dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), and arrhythmogenic cardiomyopathy (ACM). This article reviews the imaging characteristics of AH across various modalities, emphasizing echocardiography, cardiac magnetic resonance (CMR), and cardiac computed tomography as primary tools for evaluating cardiac function and distinguishing physiological adaptations from pathological conditions. The findings highlight the need for precise diagnostic criteria and advanced imaging techniques to ensure accurate differentiation, preventing misdiagnosis and its associated risks, such as sudden cardiac death (SCD). Understanding these adaptations and employing the appropriate imaging methods are crucial for athletes’ effective management and health optimization. Full article
Show Figures

Figure 1

Figure 1
<p>Clinical approach to the evaluation of athlete’s heart.</p>
Full article ">Figure 2
<p>Transthoracic echocardiography (TTE) and cardiac magnetic resonance (CMR) from a patient with athlete’s heart. TTE showed left ventricular hypertrophy and borderline left ventricle diameters (<b>A</b>), maintaining normal diastolic (<b>B</b>) and systolic function with normal GLS (<b>C</b>). CMR confirmed the diagnosis of athletic adaptation, showing concentric left ventricular hypertrophy most marked in the mid-region of the lateral wall (19 mm), without LGE (<b>D</b>–<b>F</b>). Left ventricle ejection fraction EF is 69%. Notably, the wall thickness regressed with a period of detraining.</p>
Full article ">Figure 3
<p>Patient 1 (<b>A</b>): A patient with left ventricular hypertrophy in transthoracic echocardiography who exhibits delayed gadolinium enhancement in the region of the anterior septum on CMR. Patchy enhancement is focal, with another tiny enhancement seen along the base in the mid-septum, compatible with HCM. Patient 2 (<b>B</b>): A patient with increased left ventricle diameters and mildly reduced systolic function in echocardiography. CMR findings were consistent with dilated, nonischemic cardiomyopathy, confirming the left ventricle dilatation and decreased global systolic dysfunction. Patient 3 (<b>C</b>): A patient with ARVC who showed severe right ventricle and right atria dilation with diminished right ventricle function. Extensive sacculation, right ventricle hypertrophy, and enlargement are consistent with the diagnosis of ARVC. The extensive LGE along the right ventricle free wall and right-sided interventricular septum further support this diagnosis.</p>
Full article ">Figure 4
<p>Imaging findings in athlete’s heart and important differential cardiomyopathies.</p>
Full article ">
20 pages, 3225 KiB  
Review
Converging Pathways between Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) and Diabetes in Children
by Maria Felicia Faienza, Ilaria Farella, Mohamad Khalil and Piero Portincasa
Int. J. Mol. Sci. 2024, 25(18), 9924; https://doi.org/10.3390/ijms25189924 (registering DOI) - 14 Sep 2024
Viewed by 291
Abstract
In the past thirty years, childhood obesity rates have risen significantly worldwide, affecting over 340 million children in affluent nations. This surge is intricately tied to metabolic disorders, notably insulin resistance, type 2 diabetes mellitus (T2DM), and the continually evolving spectrum of metabolic-associated [...] Read more.
In the past thirty years, childhood obesity rates have risen significantly worldwide, affecting over 340 million children in affluent nations. This surge is intricately tied to metabolic disorders, notably insulin resistance, type 2 diabetes mellitus (T2DM), and the continually evolving spectrum of metabolic-associated (dysfunction) steatotic liver disease (MASLD). This review underscores the alarming escalation of childhood obesity and delves comprehensively into the evolving and dynamic changes of nomenclature surrounding diverse conditions of hepatic steatosis, from the initial recognition of non-alcoholic fatty liver disease (NAFLD) to the progressive evolution into MASLD. Moreover, it emphasizes the crucial role of pediatric endocrinologists in thoroughly and accurately investigating MASLD onset in children with T2DM, where each condition influences and exacerbates the progression of the other. This review critically highlights the inadequacies of current screening strategies and diagnosis, stressing the need for a paradigm shift. A proposed solution involves the integration of hepatic magnetic resonance imaging assessment into the diagnostic arsenal for children showing insufficient glycemic control and weight loss post-T2DM diagnosis, thereby complementing conventional liver enzyme testing. This holistic approach aims to significantly enhance diagnostic precision, fostering improved outcomes in this vulnerable high-risk pediatric population. Full article
(This article belongs to the Special Issue Molecular Insights and Therapy in Diabetes)
Show Figures

Figure 1

Figure 1
<p>Diagnostic criteria related to novel nomenclatures indicative of diverse clinical entities associated with initial steatotic liver disease. In the presence of liver steatosis testified by specific serum biomarkers, imaging (usually liver ultrasound diagnosing “bright” hyperechoic liver), or liver biopsy and histology. (A) The diagnosis of non-alcoholic fatty liver disease (NAFLD) is based on the exclusion of steatogenic causes [<a href="#B12-ijms-25-09924" class="html-bibr">12</a>]. (B) The diagnosis of metabolic dysfunction–associated fatty liver disease (MAFLD) is based on the presence of overweight/obesity or type 2 diabetes or, in lean/normal weight individuals, accumulating at least two out of seven cardiometabolic risk abnormalities [<a href="#B17-ijms-25-09924" class="html-bibr">17</a>,<a href="#B18-ijms-25-09924" class="html-bibr">18</a>]. (C) The diagnosis of metabolic dysfunction–associated steatotic liver disease (MASLD) is part of the initial condition of steatotic liver disease (SLD). The pathway of MASLD takes into account the adult and pediatric age and requires at least one out of five cardiometabolic risk abnormalities and no other discernible cause. The criterion of weekly alcohol consumption becomes important to further classify the steatotic liver as MASLD (no or little alcohol consumption), combined metabolic dysfunction–associated alcoholic liver disease (MetALD), or pure alcoholic liver disease (ALD). The specific etiologies of steatotic liver or cryptogenic liver disease need also to be considered according to specific cases when finalizing the diagnosis of MASLD [<a href="#B19-ijms-25-09924" class="html-bibr">19</a>,<a href="#B20-ijms-25-09924" class="html-bibr">20</a>,<a href="#B25-ijms-25-09924" class="html-bibr">25</a>]. Partly created with BioRender.com (accessed on 1 August 2024).</p>
Full article ">Figure 2
<p>Metabolic dysfunction–associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is characterized by the accumulation of fat in the liver primarily due to metabolic dysregulation. The pathogenesis of MASLD is closely linked to insulin resistance, which plays a critical role in the progression of the disease. Elevated levels of free fatty acids (FFAs) in the bloodstream, often a result of increased lipolysis from adipose tissue in obesity and metabolic syndrome, are taken up by the liver and muscles. In the liver, these FFAs are esterified into triglycerides, leading to hepatic steatosis, the hallmark of MASLD. When the liver’s capacity to oxidize and store FFAs as triglycerides is exceeded, FFAs are diverted into alternative pathways, including the synthesis of diacylglycerol (DAG). Within hepatocytes, FFAs are esterified with glycerol-3-phosphate to form DAG, which acts as a second messenger to activate specific isoforms of protein kinase C (PKC), such as PKCε in the liver. The activation of PKCε results in its translocation to the cell membrane, where it phosphorylates serine/threonine residues on insulin receptor substrates (IRS-1 and IRS-2), impairing insulin signaling pathways. This impairment leads to reduced activation of Akt, decreased glycogen synthesis, and increased gluconeogenesis, contributing to hyperglycemia and worsening insulin resistance. As MASLD progresses, the chronic overload of FFAs enhances triglyceride synthesis and fatty acid oxidation, resulting in the production of reactive oxygen species (ROS). These ROS cause oxidative stress and cellular damage, triggering inflammatory responses that can escalate the disease from simple steatosis to non-alcoholic steatohepatitis (NASH). The chronic inflammation associated with NASH stimulates the production of pro-inflammatory cytokines and chemokines, which attract inflammatory cells to the liver, further aggravating hepatic injury. Over time, the persistent inflammation and oxidative stress can lead to the development of fibrosis as the liver attempts to repair the ongoing damage. This fibrotic process can progress to cirrhosis, where the liver structure is severely compromised, leading to a decline in liver function and an increased risk of hepatocellular carcinoma. Thus, MASLD represents a spectrum of liver disease that ranges from simple hepatic steatosis to varying degrees of fibrosis, cirrhosis, and potential liver failure.</p>
Full article ">
14 pages, 1182 KiB  
Article
Synthesis and Evaluation of 99mTc(CO)3 Complexes with Ciprofloxacin Dithiocarbamate for Infection Imaging
by Afroditi Papasavva, Nektarios N. Pirmettis, Antonio Shegani, Eleni Papadopoulou, Christos Kiritsis, Maria Georgoutsou-Spyridonos, Dimitrios C. Mastellos, Aristeidis Chiotellis, Patricia Kyprianidou, Maria Pelecanou, Minas Papadopoulos and Ioannis Pirmettis
Pharmaceutics 2024, 16(9), 1210; https://doi.org/10.3390/pharmaceutics16091210 (registering DOI) - 14 Sep 2024
Viewed by 155
Abstract
Background: The accurate diagnosis of bacterial infections remains a critical challenge in clinical practice. Traditional imaging modalities like computed tomography (CT) and magnetic resonance imaging (MRI) often fail to distinguish bacterial infections from sterile inflammation. Nuclear medicine, such as technetium-99m (99mTc) [...] Read more.
Background: The accurate diagnosis of bacterial infections remains a critical challenge in clinical practice. Traditional imaging modalities like computed tomography (CT) and magnetic resonance imaging (MRI) often fail to distinguish bacterial infections from sterile inflammation. Nuclear medicine, such as technetium-99m (99mTc) radiopharmaceuticals, offers a promising alternative due to its ideal characteristics. Methods: This study explores the development of [2 + 1] mixed-ligand 99mTc-labeled ciprofloxacin dithiocarbamate (Cip-DTC) complexes combined with various phosphine ligands, including triphenylphosphine (PPh3), tris(4-methoxyphenyl)phosphine (TMPP), methyl(diphenyl)phosphine (MePPh2), dimethylphenylphosphine (DMPP), and 1,3,5-triaza-7-phosphaadamantane (ADAP). The characterization of 99mTc-complexes was conducted using rhenium analogs as structural models to ensure similar coordination. Results: Stability studies demonstrated the high integrity (97–98%) of the complexes under various conditions, including cysteine and histidine challenges. Lipophilicity studies indicated that complexes with higher logD7.4 values (1.6–2.7) exhibited enhanced tissue penetration and prolonged circulation. Biodistribution studies in Swiss Albino mice with induced infections and aseptic inflammation revealed distinct patterns. Specifically, the complex fac-[99mTc(CO)3(Cip-DTC)(PPh3)] (2′) showed high infected/normal muscle ratios (4.62 at 120 min), while the complex fac-[99mTc(CO)3(Cip-DTC)(TMPP)] (3′) demonstrated delayed but effective targeting (infected/normal muscle ratio of 3.32 at 120 min). Conclusions: These findings highlight the potential of 99mTc-labeled complexes as effective radiopharmaceuticals for the differential diagnosis of bacterial infections, advancing nuclear medicine diagnostics. Future studies will focus on optimizing molecular weight, lipophilicity, and stability to further enhance the diagnostic specificity and clinical utility of these radiopharmaceuticals. Full article
Show Figures

Figure 1

Figure 1
<p>Synthesis of rhenium complexes <b>1</b>–<b>6</b>: (<b>i</b>) method A: H<sub>2</sub>O, 50 °C, 4 h; (<b>ii</b>) methanol, 50 °C, 4 h; (<b>iii</b>) method B: methanol, reflux, 2 h; (<b>iv</b>) method C: P (TMPP, MePPh2, DMPP, or ADAP), 50 °C, 4 h.</p>
Full article ">Figure 2
<p>Radiosynthesis of technetium-99m complexes <b>1′</b>–<b>6′</b>.</p>
Full article ">Figure 3
<p>Representative comparative reverse-phase HPLC chromatograms: UV detection at 254 nm of complex <b>4</b> (solid). radiometric detection of complex <b>4′</b> (dash).</p>
Full article ">
8 pages, 4150 KiB  
Article
Whole-Head Noninvasive Brain Signal Measurement System with High Temporal and Spatial Resolution Using Static Magnetic Field Bias to the Brain
by Osamu Hiwaki
Bioengineering 2024, 11(9), 917; https://doi.org/10.3390/bioengineering11090917 - 13 Sep 2024
Viewed by 242
Abstract
Noninvasive brain signal measurement techniques are crucial for understanding human brain function and brain–machine interface applications. Conventionally, noninvasive brain signal measurement techniques, such as electroencephalography, magnetoencephalography, functional magnetic resonance imaging, and near-infrared spectroscopy, have been developed. However, currently, there is no practical noninvasive [...] Read more.
Noninvasive brain signal measurement techniques are crucial for understanding human brain function and brain–machine interface applications. Conventionally, noninvasive brain signal measurement techniques, such as electroencephalography, magnetoencephalography, functional magnetic resonance imaging, and near-infrared spectroscopy, have been developed. However, currently, there is no practical noninvasive technique to measure brain function with high temporal and spatial resolution using one instrument. We developed a novel noninvasive brain signal measurement technique with high temporal and spatial resolution by biasing a static magnetic field emitted from a coil on the head to the brain. In this study, we applied this technique to develop a groundbreaking system for noninvasive whole-head brain function measurement with high spatiotemporal resolution across the entire head. We validated this system by measuring movement-related brain signals evoked by a right index finger extension movement and demonstrated that the proposed system can measure the dynamic activity of brain regions involved in finger movement with high spatiotemporal accuracy over the whole brain. Full article
(This article belongs to the Special Issue Neuroimaging Techniques for Wearable Devices in Bioengineering)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Measurement of neural signals in the cerebral cortex using a static magnetic field. (1) A static magnetic field generated by a coil on the scalp passes through the region of the cerebral cortex below the coil. (2) Static magnetic field fluctuates according to neural electromagnetic activity in the cerebral cortex through which the static magnetic field passes. (3) Magnetic sensor at the top of the coil measures neural activity in the cerebral cortex as a fluctuation in the magnetic field.</p>
Full article ">Figure 2
<p>(<b>a</b>) Noninvasive whole-head system for measuring brain signals under static magnetic field bias. A total of 159 pairs of magnetic sensors and coils were placed on the scalp with a neoprene cap. (<b>b</b>) Each magnetic sensor was connected to a coil using a plastic nut.</p>
Full article ">Figure 3
<p>Grand averages of movement-related signals evoked by extension of the right index finger were measured in three participants using the developed whole-head MBP system. Signals for all 159 channels across the scalp surface are presented as if looking down on the scalp surface with the nose (anterior) at the top.</p>
Full article ">Figure 4
<p>(<b>Left</b>) Movement-related signals of channels (A) and (B) in <a href="#bioengineering-11-00917-f003" class="html-fig">Figure 3</a>. Gray lines indicate the standard deviation at each sampling time. (<b>Right</b>) Topographies of signal distributions across the scalp at selected time points: −1500 ms, −1000 ms, 30 ms, and 140 ms. Maps are presented as if looking down on the scalp surface with the nose (anterior) at the top. Positive and negative signals are shown in red and blue, respectively.</p>
Full article ">
16 pages, 1308 KiB  
Review
Correlating Ultrastructural Changes in the Invasion Area of Colorectal Cancer with CT and MRI Imaging
by Joanna Urbaniec-Stompór, Maciej Michalak and Janusz Godlewski
Int. J. Mol. Sci. 2024, 25(18), 9905; https://doi.org/10.3390/ijms25189905 - 13 Sep 2024
Viewed by 199
Abstract
The cancer invasion of the large intestine, a destructive process that begins within the mucous membrane, causes cancer cells to gradually erode specific layers of the intestinal wall. The normal tissues of the intestine are progressively replaced by a tumour mass, leading to [...] Read more.
The cancer invasion of the large intestine, a destructive process that begins within the mucous membrane, causes cancer cells to gradually erode specific layers of the intestinal wall. The normal tissues of the intestine are progressively replaced by a tumour mass, leading to the impairment of the large intestine’s proper morphology and function. At the ultrastructural level, the disintegration of the extracellular matrix (ECM) by cancer cells triggers the activation of inflammatory cells (macrophages) and connective tissue cells (myofibroblasts) in this area. This accumulation and the functional interactions between these cells form the tumour microenvironment (TM). The constant modulation of cancer cells and cancer-associated fibroblasts (CAFs) creates a specific milieu akin to non-healing wounds, which induces colon cancer cell proliferation and promotes their survival. This review focuses on the processes occurring at the “front of cancer invasion”, with a particular focus on the role of the desmoplastic reaction in neoplasm development. It then correlates the findings from the microscopic observation of the cancer’s ultrastructure with the potential of modern radiological imaging, such as computer tomography (CT) and magnetic resonance imaging (MRI), which visualizes the tumour, its boundaries, and the tissue reactions in the large intestine. Full article
(This article belongs to the Special Issue Molecular Mechanisms and Therapies of Colorectal Cancer 3.0)
Show Figures

Figure 1

Figure 1
<p>The role of enzymes and signalling molecules involved in promotion and progression of CRC.</p>
Full article ">Figure 2
<p>Comparison of two different growth patterns of large intestine cancer. The first one is expansive, with a well-demarcated tumour mass boundary, which pushes away the healthy tissue. The second one is infiltrative, without a demarcated mass boundary, with cords of cancer cells invading the healthy tissue.</p>
Full article ">Figure 3
<p>Illustration of different T-stages of CRC and their relation to layers of rectum.</p>
Full article ">
8 pages, 549 KiB  
Article
Hypermobile Anterior Horn of the Lateral Meniscus: A Retrospective Case-Series Study of Presentation, Imaging, Treatment, and Outcomes
by Chang-Hao Lin, Chen-Hao Chiang, Wei-Chen Hung and Wei-Hsing Chih
Medicina 2024, 60(9), 1497; https://doi.org/10.3390/medicina60091497 - 13 Sep 2024
Viewed by 208
Abstract
Background and Objectives: Hypermobility of the lateral meniscus is typically associated with the posterior part of this structure, with occurrences in the anterior part rarely reported. However, a hypermobile anterior horn of the lateral meniscus can manifest clinical symptoms. This study aimed [...] Read more.
Background and Objectives: Hypermobility of the lateral meniscus is typically associated with the posterior part of this structure, with occurrences in the anterior part rarely reported. However, a hypermobile anterior horn of the lateral meniscus can manifest clinical symptoms. This study aimed to increase awareness regarding hypermobility in the anterior horn of the lateral meniscus by presenting its clinical presentations, magnetic resonance imaging (MRI) findings, arthroscopic findings, treatment approaches, postoperative protocols, and clinical outcomes. Materials and Methods: A retrospective case-series involving patients diagnosed as having hypermobile anterior horn of the lateral meniscus through arthroscopy. The clinical presentations, preoperative image findings, arthroscopic findings, treatments, postoperative protocols, and clinical outcomes following meniscal stabilization were all reviewed. Results: A total of 17 patients (17 knees) with a mean age of 45.9 ± 18.4 years were analyzed. The mean follow-up period was 18.2 ± 7.6 months (range, 6–24 months). Primary symptoms included anterior lateral knee pain, tenderness in the lateral joint lines, and a locking sensation in six of the knees. MRI revealed hypodense lesions anterior to the meniscus, fluid accumulation, degenerative changes, and anterior horn deformities. Following meniscal stabilization, the Lysholm Knee Scoring Scale score increased from 65.8 ± 12.7 before surgery to 91.1 ± 9.6 at the final follow-up (p < 0.001). All the analyzed knees achieved a full range of motion by the final follow-up, with no patient experiencing any complication or requiring reoperation. Conclusions: There is no specific sign or test that can be used to detect a hypermobile anterior horn of the lateral meniscus. A thorough arthroscopic examination is essential for diagnosing hypermobility in the anterior horn of the lateral meniscus. Arthroscopic meniscal stabilization yields favorable outcomes. Full article
(This article belongs to the Section Orthopedics)
Show Figures

Figure 1

Figure 1
<p>Preoperative knee magnetic resonance images of a 59-year-old female patient, and the arthroscopic image following meniscal stabilization. (<b>A</b>). The image shows the central region of the knee, which appears normal. The meniscus structure is intact, with uniform signal intensity and no abnormal high-signal areas. (<b>B</b>). The lateral side of the knee, where a hyperintense lesion is observed anterior to the meniscus. Additionally, there is fluid accumulation at the anterior horn, which may indicate synovitis or another inflammatory reaction. (<b>C</b>). Following meniscal stabilization.</p>
Full article ">
Back to TopTop